With its novel, laser-based technology, this early-stage company hopes to displace lumpectomy as the standard of care for eliminating breast tumors after early detection. By Jim Pomager, Editor in Chief Snapshot Novian Health develops laser-based, image-guided tumor ablation therapies. Its first product, Novilase, is a minimally invasive system for treating small breast tumors during early […]
Walter Reed Bethesda Joins Novilase Clinical Trial (9 Sept 2014)
Groundbreaking Study of Laser Treatment for Breast Cancer Now Has 11 Active Trial Sites in United States and United Kingdo CHICAGO – Novian Health, developer of Novilase® Breast Therapy, announced today that Walter Reed National Military Medical Center (Bethesda, Md.) is now a participating study site in the BR-002 Novilase Clinical Trial. The multi-center study […]
Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors (2 Sept 2014)
MOUNTAIN VIEW, Calif., Sept. 2, 2014 /PRNewswire/– Based on its recent analysis of the early-stage breast tumor treatment device market, Frost & Sullivan recognizes Novian Health, Inc. with the 2014 North America Frost & Sullivan Award for Technology Innovation Leadership. Novian Health has greatly improved the treatment of breast fibroadenoma and malignant tumors with its […]
Novian Health Named Finalist for the 2014 Red Herring Top 100 North America Award (16 May 2014)
May 16, 2014 Contact: Liz Dowling, (415) 388-‐2794 Dowling & Dennis Public Relations E-mail: Liz@DowlingDennis.net Laser ablation medical device company recognized as one of the most Promising Private Companies in North American Region CHICAGO – Novian Health, developer of Novilase® Breast Therapy, announced today that it has been selected as a finalist for Red Herring’s […]